ResMed Takes New Action to Enforce Patents

ResMed (NYSE: RMD) has filed a new legal action in theInternational Trade Commission (ITC) and an amended complaint in U.S.federal court to stop the infringement of ResMed patents. ResMed filed the action against Chinese medical device manufacturer BMCMedical Co., Ltd. (BMC) and its U.S. sales subsidiary, 3B Products, LLC,(3B) asserting patent infringement by: -- The RESmart CPAP and RESmart Auto CPAP devices -- The Willow nasal pillows patient interface and the iVolve nasal mask. ResMed is asking the ITC to stop the importation and sales of these productsin the United States. ResMed has also amended a pending action in the U.S.federal court to assert additional patents that BMC and 3B are infringing.ResMed is asking the court to stop the infringement and to award damagesagainst BMC and 3B. "ResMed built its market leadership by investing in superior technology forsleep-disordered breathing therapy," said ResMed global general counsel andchief administrative officer David Pendarvis. "The proprietary technologyin our masks and flow generators makes them comfortable and user-friendly,and our data management and reporting tools create a faster, smoother pathto patient engagement. We will continue to defend our proprietary technologyby enforcing our patents against those who unfairly copy our products." About ResMed: ResMed is a global leader in the development, manufacturing and marketing ofmedical products for the diagnosis, treatment and management of respiratorydisorders, with a focus on sleep-disordered breathing. The company isdedicated to developing innovative products to improve the lives of thosewho suffer from these conditions and to increasing awareness among patientsand healthcare professionals of the potentially serious health consequencesof untreated sleep-disordered breathing. For more information on ResMed,visit www.resmed.com.